Silo Pharma Inc.
SILO | NASDAQ
$1.23
-$0.02 (-1.60%)
At close: Oct 30, 2026, 4:00 PM ET
$1.23
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 72.1K | 72.1K | 72.1K | 72.1K | 71.26K | n/a |
Cost of Revenue | 886.06K | 5.84K | 5.84K | 5.84K | 5K | n/a |
Gross Profit | -813.96K | 66.26K | 66.26K | 66.26K | 66.26K | n/a |
Operating Income | -4.28M | -4.71M | -3.86M | -3.63M | -2.74M | -2.2M |
Interest Income | 193.91K | 333.17K | 398.53K | 72.64K | 1.21K | 11.54K |
Pretax Income | -4.23M | -4.39M | -3.63M | -3.91M | 4.18M | -2.67M |
Net Income | -4.23M | -4.39M | -3.7M | -3.91M | 3.9M | -3.04M |
Selling & General & Admin | 2.15M | 2.4M | 3.08M | 2.43M | 2.27M | 2.18M |
Research & Development | 2.16M | 2.37M | 845.09K | 1.29M | 693.91K | 26.25K |
Other Expenses | -841.76K | n/a | n/a | -20K | -148.5K | n/a |
Operating Expenses | 3.47M | 4.77M | 3.92M | 3.69M | 2.81M | 2.2M |
Interest Expense | 37.3K | 5.08K | 4.87K | 2.2K | 3.04K | 269.27K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.35M | 4.78M | 3.93M | 3.7M | 2.82M | 2.2M |
Income Tax Expense | n/a | n/a | n/a | n/a | 24.88K | n/a |
Shares Outstanding (Basic) | 558.82K | 245.36K | 205.32K | 152.28K | 126.49K | 87.94K |
Shares Outstanding (Diluted) | 558.82K | 245.36K | 205.32K | 152.28K | 127.9K | 87.94K |
EPS (Basic) | -7.50 | -17.85 | -18 | -25.65 | 19.80 | -35.25 |
EPS (Diluted) | -7.50 | -17.85 | -18 | -25.65 | 19.50 | -35.25 |
EBITDA | -4.18M | -4.38M | -3.63M | -3.91M | 4.19M | -2.4M |
EBIT | -4.19M | -4.39M | -3.63M | -3.91M | 4.19M | -2.4M |
Depreciation & Amortization | 11.44K | 6.19K | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove SILO